Xylem Inc Stock News

Xylem's (XYL) fourth-quarter performance is expected to have benefited from strong demand across end markets and price realization, partially offset by cost inflation and forex woes.

Xylem's (XYL) fourth-quarter performance is expected to have benefited from strong demand across end markets and price realization, partially offset by cost inflation and forex woes.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

The big news this week concerned an acquisition.

Johnson Controls' (JCI) Q1 earnings are expected to have benefited from global heat pump demand and backlog strength. However, supply-chain and cost woes are likely to have hurt performance.

Supply-chain disruptions and raw material cost inflation are likely to have hurt Honeywell's (HON) Q4 earnings. Pricing actions are expected to have partly offset the adversity.

Robust semiconductor business and strong organic growth in North America, Europe and China are likely to have aided Illinois Tool's (ITW) Q4 performance. High costs might have dented earnings.

Parker-Hannifin (PH) performance is likely to have benefited from strong demand across end markets, supply-chain management and effective pricing. High raw material costs might have weighed on its per

Xylem's Patrick Decker and Evoqua's Ron Keating, both CEOs of the water technology firms, discuss the $7.5 billion deal.

Healthy demand for aerospace fasteners and recovery in narrow-body and wide-body OEM production in Industrial Segment are likely to have aided Stanley Black's (SWK) Q4 performance. Input cost increase

Fabrinet and Constellation Brands are part of the Zacks Bull and Bear of the Day article.

Xylem just announced they have agreed to acquire Evoqua, offering 0.48 shares of Xylem per Evoqua share. Management expects the transaction to generate scale benefits, and to result in ~$140 million i

Pentair's (PNR) fourth-quarter 2022 performance is likely to reflect its inventory correction efforts through the quarter, seasonal factors and inflated costs and supply-chain issues.

Caterpillar's (CAT) fourth-quarter results are likely to reflect high demand in its end markets, seasonal factors, favorable price realization and savings from its cost-reduction efforts.

Upgrades UBS upgraded the previous rating for Universal Health Services Inc (NYSE:UHS) from Sell to Neutral. For the third quarter, Universal Health Services had an EPS of $2.54, compared to year-ago